Telomerase, a ribonucleoprotein enzyme complex, possesses the remarkable ability to add repetitive DNA sequences known as telomeres to chromosome termini, thereby preserving genomic stability. These telomeric regions are critical for protecting chromosomes from degradation and preventing the loss of genetic information during cell division. The catalytic subunit of this enzyme, termed TERT (telomerase reverse transcriptase), works in concert with an RNA component that provides the template for telomere elongation. However, understanding the extent to which human TERT can functionally operate within the cellular environments of other species has remained elusive until now.

The research team, led by Raúl Sánchez-Vázquez and Paula Martínez under the guidance of María A. Blasco at the Spanish National Cancer Centre (CNIO) in Madrid, embarked on an ambitious investigation. They introduced the human TERT gene into primary lung fibroblasts harvested from a diverse array of mammalian species commonly employed in preclinical models, including the cynomolgus monkey, pig, rabbit, rat, dog, and mouse. This cross-species experimental design enabled the assessment of human telomerase activity beyond solely human cells.

Initial in vitro analyses highlighted that recombinant human TERT was indeed capable of assembling enzymatically active telomerase complexes with the endogenous telomerase RNA components of multiple species—namely monkeys, pigs, rabbits, and rats. This biochemical compatibility suggested a degree of molecular conservation in the telomerase machinery across mammals. However, the study stepped beyond this reductionist biochemical perspective to evaluate functional outcomes within living cells, where regulatory networks and protein interactions dictate enzyme activity.

Strikingly, the researchers found that only cells derived from humans and non-human primates demonstrated sustained telomere elongation following infection with human TERT. In these cells, progressive extension of telomere length was measurable over time in culture, indicating effective integration and functional activity of the human telomerase enzyme. Conversely, cells from other examined species failed to maintain telomere length, despite some showing detectable telomerase activity initially. This discrepancy underscores the critical influence of complex species-specific factors that govern telomerase function in vivo, which are absent in simplified biochemical assays.

Further complicating the picture, notable deficiencies in supporting human TERT were observed within murine and canine fibroblasts. These cells not only lacked productive telomere extension but exhibited reduced viability and hallmarks of cellular stress upon expression of the human telomerase component. These findings suggest intrinsic incompatibilities that may stem from divergent regulatory protein networks, post-translational modifications, or chromatin environments that are incompatible with the human enzyme.

This study compellingly emphasizes the limitations inherent in applying common laboratory animal models such as mice and dogs for preclinical research targeting telomerase-based therapeutic strategies. Since telomerase biology is tightly controlled by a nexus of interacting factors that differ significantly across species, therapeutic approaches relying on human TERT function will likely require validation in models that recapitulate human telomerase dynamics more faithfully, particularly non-human primates.

The data affirm prior suspicions that biochemical reconstitution of telomerase activity in vitro does not guarantee successful functional integration in the cellular milieu. The recruitment of telomerase to telomeres, its stabilization, and regulation depend on accessory proteins and epigenetic factors that are species-specific, imposing barriers to cross-species enzyme functionality. Understanding these interdependencies provides crucial insights into the challenges faced when translating telomerase therapies from bench to bedside.

Given the pivotal role telomerase plays not only in normal cellular aging but also in pathological conditions such as cancer and telomere syndromes, elucidating species-specific functional compatibility is of paramount importance. The identification of non-human primate cells as uniquely permissive hosts for human TERT activity establishes them as the most appropriate in vivo platforms for preclinical studies aiming to evaluate telomerase-targeting interventions or regenerative medicine applications.

This work paves the way for refined animal modeling in aging research, offering a more faithful reproduction of human telomerase biology that is essential for assessing the efficacy and safety of potential drugs or gene therapies. By narrowing the translational gap, these findings enhance prospects for developing treatments that could delay cellular senescence, improve tissue regeneration, and ameliorate age-related diseases with telomere shortening components.

In conclusion, the investigation by the CNIO team represents a substantial advance in our understanding of telomerase biology across species barriers. The revelation that cellular context profoundly influences human TERT function redefines the parameters for selecting experimental models and prioritizes non-human primates in telomerase research. This nuanced perspective is critical for advancing therapeutic strategies that harness telomerase to combat aging and extend healthy lifespan.

Subject of Research: Cells
Article Title: Cross species activity of TERT human telomerase component
News Publication Date: 13-Apr-2026
Web References: https://doi.org/10.18632/aging.206372
Image Credits: © 2026 Raúl et al., distributed under the terms of the Creative Commons Attribution License (CC BY 4.0)
Keywords: telomerase, telomeres, molecular genetics, aging, chromosome stability, cross-species enzyme activity

DNA double-strand breaks (DSBs) are among the most deleterious forms of genomic damage. Cells repair these lesions primarily through two pathways: homologous recombination (HR), which is largely error-free, and non-homologous end joining (NHEJ), often considered a mutagenic, error-prone process. The fidelity of NHEJ varies significantly among species and is a critical factor in mutagenesis and age-related genomic instability. The research on bowhead whales has put the spotlight on NHEJ, revealing that this pathway operates with remarkably higher accuracy in bowhead whales compared to humans and other mammals such as cows and mice.

To investigate this phenomenon, scientists utilized advanced genomic engineering techniques including CRISPR-Cas9 to induce targeted double-strand breaks within the PTEN gene—a highly conserved locus across mammalian species. PTEN is a tumor suppressor gene, and its integrity is critical for cellular homeostasis. The deliberate introduction of breaks at a precise location allowed for a comparative analysis of mutation frequencies arising from NHEJ repair in cells isolated from bowhead whales, humans, cows, and mice. Deep sequencing of these repair junctions formed the backbone of the study, enabling the dissection of repair accuracy and mutation spectrum.

The compelling findings indicate that bowhead whale cells exhibited a markedly higher proportion of unmodified alleles following the CRISPR-induced breaks compared with the other species tested. This suggests that the bowhead whale’s NHEJ machinery minimizes deletions and insertions better than its mammalian counterparts, preserving the original DNA sequence more faithfully. Whereas human, cow, and mouse cells predominantly exhibited nucleotide deletions at repair sites, bowhead whale cells tended to retain sequence integrity, eschewing the mutagenic consequences often associated with NHEJ pathways.

Moreover, analysis extended beyond just small indels—larger deletions, which are known to contribute significantly to genomic instability and disease development, were also far less frequent in bowhead whale fibroblasts. This reduction in extensive genomic deletions further underscores the enhanced conservatism of the bowhead whale’s DNA repair strategy. Notably, these results were obtained without alterations in microhomology-mediated end joining use, indicating that the fidelity enhancements likely stem from intrinsic biochemical or structural properties within the NHEJ repair proteins or their regulatory networks.

The practical implications of these findings ripple beyond marine biology or whale conservation; they extend into human health research fields including cancer biology, aging, and regenerative medicine. The high-fidelity NHEJ repair observed in bowhead whales may provide a unique template or model for engineering more precise DNA repair mechanisms in human cells, potentially mitigating age-related genomic decay or the mutagenic fallout from environmental stressors.

Interestingly, the study also ruled out differential CRISPR editing efficiencies as a confounding factor, with all species exhibiting comparable levels of break induction. This strengthens the conclusion that the divergence in repair outcomes results from intrinsic differences in NHEJ pathway fidelity rather than discrepancies in initial DNA damage or break induction efficiency. Such rigor is vital for the robustness of interspecies comparative genomic studies, especially when extrapolating findings to broader biological contexts.

While many mammals rely heavily on error-prone NHEJ to rapidly patch DNA breaks—a trade-off favoring speed over precision—the bowhead whale appears to have evolved sophisticated modifications that enhance repair accuracy without sacrificing repair capability. These adaptations may be instrumental in maintaining genomic integrity over the species’ unusually long lifespan, helping to stave off age-related pathologies like cancer or degenerative diseases that are precipitated by adverse DNA repair outcomes.

Molecular analyses of bowhead whale repair proteins may reveal unique amino acid substitutions, altered protein-protein interactions, or differential regulatory elements that contribute to this exceptional repair accuracy. Furthermore, epigenetic factors or distinct cellular environments may reinforce or modulate repair fidelity, providing multiple layers of genomic safeguarding. Understanding these layers could lead to the development of novel therapeutic strategies aimed at enhancing DNA repair fidelity in human somatic cells.

The interdisciplinary research combining molecular biology, genomics, and evolutionary biology offers a vivid demonstration of how comparative studies across species can uncover new biological principles. The bowhead whale stands as a natural experiment in evolutionary biology, highlighting the remarkable plasticity of fundamental cellular processes like DNA repair in response to selective pressures driving extended longevity and organismal resilience.

In the broader scientific discourse, this revelation complements prior evidence linking longevity with enhanced genome maintenance mechanisms, including telomere preservation, oxidative stress resistance, and meticulous proteostasis. It adds a critical dimension by elucidating how the repair of critical genome lesions themselves can be sculpted by evolution to support longer life spans and reduced mutation accumulation.

Future research directions will likely focus on characterizing the molecular determinants of enhanced NHEJ fidelity in bowhead whales, identifying homologous pathways or genes amenable to manipulation in other species. Additionally, exploring how these repair mechanisms interface with other cellular longevity pathways may yield integrative models that explain lifespan regulation at a system-wide level.

As genomic medicine advances, the bowhead whale’s precision DNA repair blueprint could inspire innovative therapeutic approaches, from cancer prevention strategies to anti-aging interventions. This research not only unravels a fascinating evolutionary adaptation but also opens new avenues to harness nature’s solutions to genome stability challenges.

Ultimately, the bowhead whale offers a testament to the power of evolution to fine-tune cellular processes and protect life’s genetic instructions far more faithfully than previously appreciated. This discovery enriches our understanding of longevity and could pave the way toward redefining how we approach health span extension in humans, inspiring hope for future breakthroughs grounded in nature’s profound ingenuity.

Subject of Research: DNA repair fidelity in the bowhead whale comparing non-homologous end joining (NHEJ) to other mammals.

Article Title: Evidence for improved DNA repair in long-lived bowhead whale.

Article References:
Firsanov, D., Zacher, M., Tian, X. et al. Evidence for improved DNA repair in long-lived bowhead whale. Nature (2025). https://doi.org/10.1038/s41586-025-09694-5

Image Credits: AI Generated